Two competing proteins affect the chronic inflammation of the nervous system following viral infection

May 9, 2014
Figure 1: Inflammation of the central nervous system following a viral infection can lead to fatigue and depression depending on the competing activity of two cytokine proteins. Credit: imtmphoto/iStock/Thinkstock

Fatigue and depression are common during and after viral infection, and in some cases can become chronic long-term ailments. Fever and inflammation associated with viral infections are triggered by the release of proinflammatory proteins called cytokines. These proteins can also trigger persistent inflammation of the central nervous system, or neuroinflammation, which is thought to be a key factor in the onset of viral-related depression and fatigue. The exact molecular mechanisms involved, however, are not fully understood.

Yosky Kataoka, Masanori Yamato and colleagues from the RIKEN Center for Life Science Technologies have now uncovered the roles of two cytokines, interleukin 1 beta (IL-1β) and its receptor antagonist IL-1ra, in triggering and controlling neuroinflammation in rats.

When faced with viral infection, the body's immune system responds by releasing cytokines. Overexpression of specific cytokines known as interferon alpha (IFN-α) in the brain can trigger long-term neuroinflammation. Previous research has shown that injecting animals with a synthetic double-stranded RNA called poly I:C, which mimics the activity of a virus in the body, induces a decrease in behavioral activity caused by IFN-α overexpression in the brain. Kataoka's team conducted a series of experiments involving poly I:C injection in rats, and found that levels of spontaneous behavior in the rats fell significantly after injection, yet showed signs of recovery after a week.

"We wanted to expand on previous studies and work out which mechanisms tip the balance towards more chronic problems," says Kataoka. "We focused on two main , IL-1β, and its competing molecule IL-1ra."

By injecting IL-1β into the rat brain, the team generated the same dip in spontaneous activity as observed following poly I:C injection, showing that IL-1β was responsible for inducing the production of IFN-α and therefore influencing levels of neuroinflammation. "We also noted that IL-1ra is a functional regulator of IL-1β," mentions Kataoka.

The researchers demonstrated that blocking the efficacy of IL-1ra in the brain delayed the rats' recovery still further. Infusion of IL-1ra into the brains of rats injected with poly I:C, on the other hand, arrested the depressive behavior.

"These results indicate that IL-1ra has an important role in preventing neuroinflammation entering a chronic state," explains Kataoka. "Maintaining a careful balance in the production of IL-1β and IL-1ra is therefore crucial for healthy function."

Explore further: Researchers identify risks for death from H7N9 avian flu virus

More information: Yamato, M., Tamura, Y., Eguchi, A., Kume, S., Miyashige, Y., Nakano, M., Watanabe, Y. & Kataoka, Y. "Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats." PLoS ONE 9, e90950 (2014).
DOI: 10.1371/journal.pone.0090950

Related Stories

Researchers identify risks for death from H7N9 avian flu virus

December 24, 2013
(Medical Xpress)—Since March 2013, the avian flu virus H7N9 has infected 134 people and caused 44 deaths. Among those infected, many, but not all, patients develop severe symptoms, including pneumonia and acute respiratory ...

Anti-inflammatory chemical could prevent stroke damage

December 5, 2011
(Medical Xpress) -- Drugs that block inflammation in the brain could help patients who have a stroke or a brain haemorrhage, Manchester scientists said today (5 December) at the British Society for Immunology Congress in ...

IL-27 balances the immune response to influenza and reduces lung damage

May 8, 2014
Highly pathogenic (dangerous) influenza strains elicit a strong immune response which can lead to uncontrolled inflammation in the lung and potentially fatal lung injury. A study published on May 8th in PLOS Pathogens demonstrates ...

Data on novel IL-1 inhibitor protein for topical treatment of dry eye disease published

February 18, 2013
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences showing beneficial effects ...

Study finds 'Western diet' detrimental to fetal hippocampal tissue transplants

April 23, 2012
Researchers interested in determining the direct effects of a high saturated fat and high cholesterol (HFHC) diet on implanted fetal hippocampal tissues have found that in middle-aged laboratory rats the HFHC diet elevated ...

Research shows bone loss causes joint pain from alphaviral diseases

April 15, 2014
(Medical Xpress)—Arthritogenic alphaviruses such as Ross River virus (RRV) cause disabling joint pain. To understand what causes this pain, Suresh Mahalingam of Griffith University in Australia and his team studied how ...

Recommended for you

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

July 12, 2017
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune ...

A perturbed skin microbiome can be 'contagious' and promote inflammation, study finds

June 29, 2017
Even in healthy individuals, the skin plays host to a menagerie of bacteria, fungi and viruses. Growing scientific evidence suggests that this lively community, collectively known as the skin microbiome, serves an important ...

Inflammatory bowel disease: Scientists zoom in on genetic culprits

June 28, 2017
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. The team from the Wellcome Trust Sanger Institute and their collaborators ...

Trials show unique stem cells a potential asthma treatment

June 28, 2017
A study led by scientists at Monash University has shown that a new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.

Researchers find piece in inflammatory disease puzzle

May 23, 2017
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

Researchers reveal potential target for the treatment of skin inflammation in eczema and psoriasis

May 22, 2017
Superficially, psoriasis and atopic dermatitis may appear similar but their commonalities are only skin deep. Atopic dermatitis, also known as eczema, is primarily driven by an allergic reaction, while psoriasis is considered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.